Raysearch Laboratories
190.60 SEK
-0.42 %
Less than 1K followers
RAY B
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Raysearch Laboratories
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 293.3 | 322.7 | 1,192.0 | 331.7 | 304.9 | 332.3 | 375.4 | 1,344.3 |
| EBITDA | 134.8 | 151.8 | 558.0 | 145.1 | 108.9 | 162.3 | 167.3 | 583.6 |
| EBIT | 61.8 | 73.6 | 260.5 | 74.8 | 36.4 | 89.2 | 91.9 | 292.3 |
| EBIT-% | 21.1 % | 22.8 % | 21.9 % | 22.6 % | 11.9 % | 26.8 % | 24.5 % | 21.7 % |
| Profit before taxes | 58.3 | 77.4 | 262.9 | 71.0 | 39.6 | 88.5 | 88.7 | 287.8 |
| Net income | 45.4 | 60.0 | 203.5 | 56.8 | 30.8 | 71.6 | 68.6 | 227.8 |